Cargando…
Su327 DIAGNOSIS AND CHARACTERISTICS OF IMMUNE CHECKPOINT INHIBITOR-MEDIATED CHOLANGIOPATHY: A CASE SERIES
Autores principales: | Eyada, Mostafa, Taggart, Melissa W., Wang, Lan S., Miller, Ethan D., Zhang, Hao Chi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AGA Institute. Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8108234/ http://dx.doi.org/10.1016/S0016-5085(21)02763-3 |
Ejemplares similares
-
Tu1259: CLINICAL FEATURES AND CHARACTERISTIC OF CHOLANGIOPATHY AFTER SEVERE COVID-19
por: Li, Tian, et al.
Publicado: (2022) -
Su323 THE PATTERNS OF LIVER INJURY IN COVID-19 POSITIVE PREGNANT FEMALES: A CASE SERIES
por: Raju, Sneha, et al.
Publicado: (2021) -
Su322 SEVERE CHOLESTATIC HEPATITIS SECONDARY TO SARS-COV-2
por: Lindholm, Christopher R., et al.
Publicado: (2021) -
Su316 INCREASED DIAGNOSIS OF HEPATOCELLULAR CARCINOMA IN HOSPITALIZED PATIENTS WITH ALCOHOL RELATED HEPATITIS AFTER THE COVID-19 OUTBREAK: A GLOBAL MULTI-CENTER PROPENSITY MATCHED ANALYSIS.
por: Perisetti, Abhilash, et al.
Publicado: (2021) -
Su326 IS TRANSAMINITIS AN INDEPENDENT RISK FACTOR FOR ALL-CAUSE MORTALITY IN COVID-19?
por: Mughal, Mohsin, et al.
Publicado: (2021)